Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario M5S 1A8, Canada; Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada; Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada.
Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, Quebec H3C 3J7, Canada.
Biochim Biophys Acta Gene Regul Mech. 2023 Jun;1866(2):194922. doi: 10.1016/j.bbagrm.2023.194922. Epub 2023 Feb 21.
Protein arginine methyltransferases (PRMTs) catalyze the transfer of methyl groups to specific arginine residues of histones and nonhistone proteins. There are nine members in the PRMT family (PRMT1 to PRMT9), and PRMT1 is a dominant member catalyzing majority of arginine methylation in the cell. However, none of the PRMTs is active with recombinant nucleosome as substrate in vitro. Here, we report the discovery of the first in class novel crosstalk between histone H4 lysine 20 (H4K20) monomethylation on nucleosome by SETD8 and histone H4 arginine 3 (H4R3) methylation by PRMT1 in vitro. Full kinetic characterization and mass spectrometry analysis indicated that PRMT1 is only active with recombinant nucleosomes monomethylated at H4K20 by SETD8. These data suggests that the level of activity of PRMT1 could potentially be regulated selectively by SETD8 in various pathways, providing a new approach for discovery of selective regulators of PRMT1 activity.
蛋白质精氨酸甲基转移酶(PRMTs)催化将甲基基团转移到组蛋白和非组蛋白蛋白质的特定精氨酸残基上。PRMT 家族有九个成员(PRMT1 到 PRMT9),PRMT1 是一种主要的成员,它在细胞中催化大多数精氨酸甲基化。然而,在体外,没有一种 PRMTs 以重组核小体作为底物表现出活性。在这里,我们报道了 SETD8 对核小体上组蛋白 H4 赖氨酸 20(H4K20)单甲基化和 PRMT1 对组蛋白 H4 精氨酸 3(H4R3)甲基化的首次同类新型串扰的发现。全面的动力学特征分析和质谱分析表明,PRMT1 仅在 SETD8 单甲基化的重组核小体上具有活性。这些数据表明,PRMT1 的活性水平可能在各种途径中被 SETD8 选择性地调节,为发现 PRMT1 活性的选择性调节剂提供了一种新方法。